Mid American Wealth Advisory Group Inc. Takes Position in Aflac Incorporated $AFL

Mid American Wealth Advisory Group Inc. acquired a new position in shares of Aflac Incorporated (NYSE:AFL) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 250 shares of the financial services provider’s stock, valued at approximately $26,000.

Several other institutional investors have also added to or reduced their stakes in AFL. AG2R LA Mondiale Gestion D Actifs bought a new stake in shares of Aflac in the first quarter valued at about $2,070,000. Belpointe Asset Management LLC bought a new position in shares of Aflac during the 1st quarter worth approximately $551,000. Golden State Wealth Management LLC raised its holdings in shares of Aflac by 121.9% in the first quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 167 shares during the last quarter. Strs Ohio bought a new stake in shares of Aflac in the first quarter worth $2,626,000. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its holdings in Aflac by 11.8% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 32,982 shares of the financial services provider’s stock worth $3,478,000 after purchasing an additional 3,484 shares during the last quarter. 67.44% of the stock is owned by institutional investors.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the transaction, the director owned 25,105 shares in the company, valued at approximately $2,575,019.85. This represents a 3.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.80% of the company’s stock.

Aflac Stock Performance

Shares of NYSE AFL opened at $108.77 on Tuesday. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $58.17 billion, a P/E ratio of 24.66, a P/E/G ratio of 2.99 and a beta of 0.86. Aflac Incorporated has a 12 month low of $96.95 and a 12 month high of $115.43. The stock has a 50 day moving average of $108.45 and a 200-day moving average of $105.41.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The business had revenue of $5.91 billion for the quarter. As a group, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac announced that its Board of Directors has initiated a share repurchase program on Tuesday, August 12th that permits the company to buyback 100,000,000 shares. This buyback authorization permits the financial services provider to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th were paid a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Wednesday, August 20th. Aflac’s dividend payout ratio (DPR) is currently 52.61%.

Analyst Ratings Changes

AFL has been the topic of several recent research reports. Morgan Stanley lifted their price target on shares of Aflac from $108.00 to $113.00 and gave the company an “equal weight” rating in a research note on Monday, August 18th. Barclays reiterated an “underweight” rating and set a $102.00 target price (up previously from $100.00) on shares of Aflac in a report on Wednesday, October 8th. Keefe, Bruyette & Woods boosted their price target on Aflac from $108.00 to $110.00 and gave the stock a “market perform” rating in a research report on Thursday, October 9th. Evercore ISI set a $110.00 price objective on Aflac and gave the stock an “underperform” rating in a research note on Thursday, October 9th. Finally, Wells Fargo & Company raised their target price on shares of Aflac from $105.00 to $107.00 and gave the company an “equal weight” rating in a research note on Monday, August 11th. Three analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and a consensus price target of $109.45.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.